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Abstract  
The United Kingdom health and care system is changing dramatically to meet the health challenges of the 21st century. People will 
increasingly have multiple morbidities. The focus of service delivery is changing from hospital to community, patient to population and 
curative to preventive. This paper describes the NHS and primary care and community pharmacy in England at the start of 2020, a time 
of great change. The 10-year vison for the NHS is that everyone gets the best start in life, world class care for major health problems 
supporting people to age well. It has over 40 mentions of pharmacists and pharmacy. The key aims of the plan are to improve ‘out-of-
hospital’ care, and finally dissolve the historic divide between primary and community health service in England. All of England is 
covered by integrated care systems and the newly formed primary care networks which will form the foundation of these new 
systems. Pharmacy is involved at multiple levels. There are 11,569 community pharmacies and most of their total income comes from 
the NHS (range 68-85%). Around 60% pharmacies are part of multiple chains, with the remaining 40% independents or small chains of 
less than six outlets. The new five-year community pharmacy contract provides an opportunity to develop community pharmacy and 
move towards service delivery away from dispensing volume. The new services are described under medicines optimisation, 
prevention and urgent care. The pharmacy quality scheme is also described. The new deal will help many community pharmacies to 
plan their future, particularly for those pharmacies who are ready and able to change and work closely with pharmacists and other 
health professionals in collaboration with Primary Care Networks. There will be specific challenges around: dispensing efficiencies, 
freeing up pharmacists’ time, wider use of clinical skills of community pharmacists, community pharmacy viability and consolidations. 
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INTRODUCTION 
The United Kingdom (UK) health and care system is 
changing dramatically to meet the health challenges of the 
21
st
 century. Twenty five per cent of the population have 
more than two chronic diseases, 18% of the population is 
over 65. The focus of service delivery is changing from 
hospital to community, patient to population and curative 
to preventive. The UK has a size of 93,628 m² and a 
population in October 2019 of 67,630,324. UK gross 
domestic product (GDP) in second quarter of 2019 was USD 
553,563 million. England has a population of around 56 
million and the largest share of GDP. In 2018 the UK spent 
9.8 per cent of GDP on health. GBP 18.2 billion was spent 
on medicines in England, a significant contribution to UK 
economy. This paper focusses on England as the National 
Health Service (NHS) is devolved in the UK. 
The NHS is the Government funded health care services 
that everyone living in the UK can use without being asked 
to pay the full cost of the service. The costs are covered by 
taxation. These services include: being treated at general 
practice surgery, pharmacy services, prescriptions, there is 
a fee per item cost of GBP 9 per prescription (many people 
are exempt from charges), getting treatment at a hospital if 
unwell or injured, seeing a midwife if pregnant, calling an 
ambulance and being transported to hospital and some 
dental and optometrist services.  
The NHS 10 year plan 
The NHS 10 year plan was launched in January 2019. This 
10-year vison for the NHS is: everyone gets the best start in 
life, world class care for major health problems supporting 
people to age well.
1
 It has 40 mentions of pharmacists and 
pharmacy, the largest number of mention a key policy 
document from the NHS has ever seen. The key aims of the 
plan are to improve ‘out-of-hospital’ care, and finally 
dissolve the historic divide between primary and 
community health service in England. The NHS will redesign 
and reduce pressure on emergency hospital services. 
People will get more control over their own health, and 
more personalised care when they need it. Digitally 
enabled primary and outpatient care will go mainstream 
across the NHS. Local NHS organisations will increasingly 
focus on population health and local partnerships with local 
authority-funded services, through new Integrated Care 
Systems (ICSs). The highlights are a GBP 20.5 billion budget 
settlement, GBP 4.5 billion for primary and community care 
and Primary Care Networks are the foundation for 
Integrated Care Systems.  
Primary care context  
Primary care services continue to face unprecedented and 
growing demand. This reflects widely recognised system 
pressures associated with an ageing population, 
multimorbidity and inappropriate polypharmacy. Between 
1996 and 2008, GP consultations increased by an estimated 
11%, and nurse consultations by 150%.
2
 At the same time 
spending on the NHS, and in particular, in general practice 
in Great Britain has declined.
3
 Furthermore, there are 
significant reductions in the numbers entering general 
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practice as a career, and a high rate of turnover of those 
working in the profession.
4
 The 2016 General Practice 
Forward View recognised some of the key issues in 
efficiently and effectively managing the frontline demand 
and supply of healthcare in the UK.
5
 
The Royal College of General Practitioners (RCGP) 
suggested one potential solution is to develop a more 
diverse skill mix in primary care workforce and outlines the 
fact that community pharmacy is a ‘significant unexploited 
potential’.
6
 In 2013, the Royal Pharmaceutical Society’s 
‘Now or Never’ report proposed a significant rethink of the 
models of care through which pharmacy is delivered, 
towards a model utilising the full professional expertise and 
potential of pharmacists.
7
 The Murray review of community 
pharmacy clinical services was commissioned by the Chief 
Pharmaceutical Officer for England in 2016.
8
 The review 
made several recommendations to make the most of the 
clinical services that community pharmacies can provide 
including development of repeat dispensing, management 
of people with long term conditions and clinical medication 
reviews, a common minor ailment service and a national 
smoking cessation service. It recommended using the 
pharmacy integration fund to develop new models of care. 
Murray identified a number of barriers including poor 
integration with other parts of the NHS which is hindered 
by the lack of interoperability of digital clinical systems, 
issues around behaviours and cultures including sometimes 
weak relationships between GPs and pharmacy, which in 
turn inhibit better integration and system design issues 
including the existing contractual mechanisms for 
pharmacy that are complex and poorly understood.  
The NHS long term plan gave an additional GBP 4.5 billion 
to primary medical and community health services to 
improve out of hospital care. In January 2019, NHS England 
and the British Medical Association’s GP Committee 
England agreed a five year GP contract framework aiming 
to alleviate workforce pressures on general practice, secure 
enhanced investment into primary medical care, and roll 
out new service models in collaboration with community 
services and other providers and to improve proactive and 
preventative care for patients.
9
 There are around 1,250 
primary care networks and they have a mandatory 
requirement to work with other providers like community 
pharmacy.  
All of England is covered by integrated care systems that 
bring together NHS, local authority, voluntary and 
community organisations to take responsibility for the 
resources and health of the population of a defined area by 
April 2021 and key contractual responsibilities will be with 
placed with primary care networks. Integrated care systems 
work on three levels 1) system: focusses on partners 
working together to set strategy, finance, workforce 
planning, and agree overall levels of integration. 2) Place: 
based around towns within a system, work at ‘place’ level 
centres on the planning of localised services and the 
delivery of secondary and community care. 3) 
Neighbourhood: this level is based around Primary care 
Networks), groups of GP practices and other providers 
covering populations of 30,000 to 50,000 people. Multi-
disciplinary teams will be central to Primary Care Networks, 
with clinicians and health and care professionals from a 
wide range of services including pharmacists working 
together to provide primary and community care. This 
approach reinforces the strategic direction toward place 
based, population health. 
A group of clinical priorities have been chosen for their 
impact on the population’s health: cancer, cardiovascular 
disease, maternity and neonatal health, mental health, 
stroke, diabetes and respiratory care. There is also a focus 
on people’s entire lives from birth to endo of life.  
Alongside primary care networks, the plan commits to 
developing ‘fully integrated community-based health care’. 
This will involve developing multidisciplinary teams, 
including GPs, pharmacists, district nurses, and allied health 
professionals working across primary care and hospital 
sites.  
The GP contract framework set out seven national services 
specifications that will be added to the Network Contract 
Directed Enhanced Services, five starting from April 2020, 
and a further two from April 2021. The seven proposed 
services are: structured medication reviews and 
optimisation, enhanced health in care homes (jointly with 
community services providers), Anticipatory care (jointly 
with community services providers), personalised care and 
supporting early cancer diagnoses. The first five were 
planned to be implemented from April 2020 With CVD and 
tackling neighbour inequalities supposedly coming in from 
April 2021 subject to agreement over contracts.  
There is also a move to support more digital engagement 
with patients, over the next five years every patient will get 
the right to telephone or online consultations, usually with 
their own practice, with the emphasis on digital access. For 
outpatients, technology will be used to redesign services to 
avoid up to a third of outpatient visits (30 million visits a 
year). 
Primary Care Networks (PCNs) will be guaranteed funding 
for an up to estimated 26,000 additional staff by 2023/24. 
This funds new roles for which there is both credible supply 
and demand. The NHS is making a financial contribution 
toward the recruitment and employment of pharmacists, 
physician associates, first contact physiotherapists, and first 
contact community paramedics; and 100% of the costs of 
additional social prescribing link workers.  
Under the 2019 GP contract framework by 2023/24, a 
typical network of 30,000-50,000 patients could choose to 
have its own team of approximately six whole time 
equivalent pharmacists. A dedicated team makes it possible 
to create varied and tailored roles: undertaking structured 
medication reviews, improving medicine optimisation and 
safety, supporting care homes, as well as running practice 
clinics. Pharmacists will be supported with an 
education/training programme alongside supervision by 
other pharmacists/healthcare professionals across the PCN. 
It is suggested that this will make it easier to support 
pharmacists’ professional and career development at 
network rather than practice level. Some of these 
pharmacists will come from the existing pharmacists in 
general practice and pharmacists on care homes schemes. 
There are some pharmacy technicians working in general 
practice complimenting the pharmacists work, and there 
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maybe considerations how such posts could be funded 
through the NHS schemes soon. 
Overview of community pharmacy in England 
NHS England currently spends nearly GBP 2.6 billion a year 
on a network of 11,569 community pharmacies. Most of 
their total income comes from the NHS (range 68-85%). 
Around 60% pharmacies are part of multiple chains, with 
the remaining 40% independents or small chains of less 
than six outlets. Following Government liberalisation of 
market entry, there are nearly 2,000 more pharmacies than 
15 years ago. 40% of pharmacies are located within a ten-
minute walk of two of more other pharmacies. There are 
an estimated 1.6millioin visits to community pharmacy 
every day, this equates to the entire population of England 
in six weeks. 
National responsibility for community pharmacy is shared 
with NHS England and the Department of Health and Social 
Care. The Pharmaceutical Services Negotiating Committee 
(PSNC) negotiates the contract on behalf of the profession 
in England. The system is governed by statutory 
arrangements, known as the Community Pharmacy 
Contractual Framework, which provides remuneration. The 
budget was reduced from GBP 2.8 billion in 2015/16, to 
GBP 2.687 billion in 2016/17, and GBP 2.592 in 2017/18. In 
2018/19 the budget remained at GBP 2.592 billion. A new 
NHS England community pharmacy contract10was agreed 
and launched in 2019. This is an unprecedented five year 
deal. It takes into account the need for pharmacies to 
engage with local Primary Care Networks (PCNs).  
All pharmacies will have to be healthy living pharmacies. 
The Healthy Living Pharmacy framework is a tiered 
commissioning framework aimed at achieving consistent 
delivery of a broad range of high quality services through 
community pharmacies to meet local need, improving the 
health and wellbeing of the local population and helping to 
reduce health inequalities.
11
 
NHS England wants to make efficiency savings through the 
transformation and reform of dispensing using automation, 
online, and changing supervision laws we are yet to see 
what the proposed approaches will be. Pharmacy services 
are divided into essential, locally commissioned and 
advanced services. Essential services include dispensing, 
promotion of healthy lifestyles, disposal of unwanted 
medicines and signposting to other services. Examples of 
locally commissioned services include smoking cessation, 
sexual health and minor ailments services. Advanced 
services include the New Medicines Service, the 
Community Pharmacy Consultation Service and the Flu 
vaccination service. The new services are discussed below 
under the flowing headings, medicines optimisation and 
safety, prevention, urgent care and the pharmacy quality 
scheme. 
 
MEDICINES OPTIMISATION AND SAFETY 
The New Medicines service 
The New Medicine Service (NMS) started in 2011. The 
service provides support for people with long-term 
conditions, newly prescribed a medicine, to help improve 
medicines adherence; it currently focusses on asthma and 
COPD, type two diabetes, antiplatelet/anticoagulant 
therapy and hypertension. It is likely to be expanded in the 
future. Following a patient‘s written consent the 
pharmacist discusses the new medicine with the patient at 
the initial consultation then books a further consultation 7-
14 days after their initial presentation with a prescription 
for a new medicine. The patient will have a third 
appointment about two weeks later. The main aim of the 
follow up consultations (which can be face-to-face or 
telephone-based) is the patient-centred identification of 
any problems either with the treatment and any support or 
action needed.  
Since the introduction of the NMS, more than 90% of 
community pharmacies in England have provided it to their 
patients. To inform the longer-term commissioning 
decision, researchers at the University of Nottingham 
evaluated the service the researchers concluded that as the 
NMS delivered better patient outcomes for a reduced cost 
to the NHS, it should be continued.
12
 Pharmacists are paid 
Community pharmacy contractors earn between GBP 20 
and GBP 28 for each completed New Medicines Service 
they provide depending on the total number of patients 
who receive the service in the month. The structure 
rewards each complete NMS provided whilst also 
encouraging the provision of the service to the greatest 
number of patients. 
To free up capacity and funding for the new Community 
Pharmacy Consultation Service, and also in recognition that 
the NHS does not consider MURs to be offering good value 
for money, MURs will be decommissioned in phased way. 
In 2020/21, a Medicines Reconciliation service will be 
introduced, to ensure that changes in medicines made in 
secondary care are implemented appropriately when the 
patient is discharged back into the community. Further 
work is required to finalise the details of this service. 
Models of such a service have been successfully piloted and 
some predicted economic benefits and reductions in 
hospital admissions have been seen. 
Structured medication reviews  
Structured medication review as defined by NICE is a 
critical examination of a person's medicines with the 
objective of reaching an agreement with the person about 
treatment, optimising the impact of medicines, minimising 
the number of medication-related problems and reducing 
waste. As mentioned above they are being funded under 
the new GP contract. At present pharmacists who are 
based in GP surgeries will carry this out along with GPs and 
nurse prescribers. Based on the primary care networks 
flexibility of working, community pharmacists and hospital 
pharmacists may also be involved in the delivery of these 
going forward.  
Further proposed services include the routine monitoring 
of patients, for example those taking oral contraception, 
being supplied under an electronic repeat dispensing 
arrangement and the testing of a new service to improve 
access to palliative care medicines. If PCN enhanced 
services free up local commissioning, then this money 
could be invested in other services that involve community 
pharmacy providers to support local population needs and 
could leads to future services/opportunities. 
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PREVENTION 
Flu vaccination service  
Community pharmacists in England have provided flu 
vaccination services since 2015. These services are in 
addition to the nationally commissioned GP vaccination 
service, giving patients another choice of venue for their 
vaccination and helping commissioners to meet their 
national NHS vaccination targets. The service demonstrates 
high levels of patient satisfaction and evidence that 
pharmacy vaccination is accessible, often capturing ‘hard to 
reach’ patients who would not otherwise take up the offer 
of vaccination. Community pharmacies. Uptake of NHS 
funded flu vaccinations in pharmacies has increased by 
90.1% from 2015/16 to 2018/19, 595,467 to 1,433,095 
vaccinations.
13
 We would hope to see more vaccinations 
delivered through community pharmacy in the future e.g. 
MMR or childhood vaccinations.  
Further prevention services 
 A Hepatitis C testing service will be introduced in 
pharmacies that provide a needle exchange service in 
2019/20. A model for detecting undiagnosed cardiovascular 
disease will be developed. Other proposed services include; 
smoking cessation support referrals from secondary care, 
point of care testing around minor illness, to support 
efforts to tackle antimicrobial resistance, The routine 
monitoring of patients, for example those taking oral 
contraception, being supplied under an electronic repeat 
dispensing arrangement; Activity complementing the 
content of forthcoming PCN service specifications, for 
example on early cancer diagnosis and in tackling health 
inequalities. 
 
URGENT CARE 
Community Pharmacist Consultation Service 
Following pilots the new Community Pharmacist 
Consultation Service was launched in October 2019.
14
 The 
service refers patients to community pharmacy from NHS 
111, the NHS telephone triage service, and is currently 
being piloted from GP surgeries, urgent care and accident 
and emergency services It improves access and educes 
demand on integrated urgent care services, urgent 
treatment centres, emergency Departments, walk in 
centres, other primary care urgent care services and GP 
Out of Hours (OOH) services, and free up capacity for the 
treatment of patients with higher acuity conditions. To 
provide the service, pharmacies must have access to the 
NHS summary care record and a consultation room, which 
must be clearly designated as an area for confidential 
consultations, it must be distinct from the general public 
areas of the pharmacy premises, it must be a room where 
both the person receiving services and the pharmacist 
providing those services are able to sit down together and 
talk at normal speaking volumes without being overheard, 
it must have IT equipment accessible within the 
consultation room to allow contemporaneous records of 
the consultations provided as part of this service to be 
made. A Consultation fee of GBP 14 is paid for each 
completed referral (urgent medicines supply or minor 
illness). Pharmacists may also sell the patient any 
appropriate medicines, but not all consultations will end in 
supply, as some will be supported with just health advice. 
 
THE PHARMACY QUALITY SCHEME  
From 2019/20, the Pharmacy Quality Scheme came into 
effect.
15
 There is GBP 75 million associated with this 
scheme and it demonstrates the shift form volume to 
quality. It has clear links with the quality improvement 
module in the GP contract to hopefully allow greater 
collaboration between GPs and community pharmacists 
especially within PCNs It includes a number of new 
requirements for pharmacies, including: preparation for 
engagement with Primary Care Networks, doing audits on 
prescribing safety around lithium, advice on pregnancy 
prevention for women taking valproate and a re-audit of 
use of non-steroidal anti-inflammatory drugs (NSAIDs); 
checking with all patients with diabetes whether they have 
had annual foot and eye checks; a reduction in the total 
volume of sugar sweetened beverages sold by the 
pharmacy to 10% or less; completion of training and 
assessment on look-alike, sound-alike (LASA) errors, 
including an update of the pharmacy’s patient safety report 
and evidence of action; completion of sepsis online training 
and assessment with risk mitigation and completion of a 
dementia friendly environment standards checklist. 
 
CHALLENGES  
The new contract secures a future for community 
pharmacies and sets out a clear vision for community 
pharmacy services. It starts to put pharmacy at the heart of 
primary care, and builds some leverage for the future. But 
there is flat funding until 2024 and no recognition of costs 
and inflation and this all comes against a backdrop of 
pressure and stress within community pharmacy. 
The new deal guarantees a future for those pharmacies 
that are ready and able to change. There will be specific 
challenges around: dispensing efficiencies, freeing up 
pharmacists’ time, wider use of clinical skills of community 
pharmacists, community pharmacy viability and 
consolidations. Pharmacists will need to effectively record 
and use data to demonstrate value. There will need to be 
additional funding to train community pharmacists as 
independent prescribers. International evidence shows that 
collaboration in primary care takes time; strong 
relationships, a shared vision and effective leadership are 
all crucial.  
Delivery of the NHS plan relies on increasing workforce 
capacity, especially in primary care. There also needs to be 
investment in diagnostic equipment and IT infrastructure, 
interoperability and access. There is also the question 
about how an agenda focussed on single diseases can be 
implemented in to meet the needs of people living with 
frailty and multiple long term conditions. Workforce 
shortages are currently the largest challenge facing the NHS 
where there is a large shortage of GPs and nurses. Moving 
pharmacists into primary care is already causing shortages 
in hospital and community sectors in some parts of 
England. There needs to be a proper, joined up workforce 
strategy for pharmacy from undergraduate through to 
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consultant level, with appropriate training and competency 
development at every stage. New services will also need 
being evaluated properly and proper rather than piecemeal 
and funding made available to do this. 
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